Instituto de Biomedicina de Sevilla -ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2023

  1. Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma

    Nature Communications, Vol. 14, Núm. 1

  2. The imperative for quality control programs in Monkeypox virus DNA testing by PCR: CIBERINFEC quality control

    Journal of Medical Virology, Vol. 95, Núm. 11

2022

  1. Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer

    Cancers

  2. Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?

    Archivos de Bronconeumologia

2019

  1. Antipruritic vs. Antitumour action of aprepitant: A question of dose

    Acta Dermato-Venereologica

2017

  1. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier

    Translational Research, Vol. 181, pp. 83-95.e3

2015

  1. Targeting NK-1 receptors to prevent and treat pancreatic cancer: A new therapeutic approach

    Cancers, Vol. 7, Núm. 3, pp. 1215-1232

2014

  1. Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts

    International Journal of Oncology, Vol. 44, Núm. 1, pp. 137-146